Medicare Enrolled
Dr. Manuel Sainz De La Pena, MD
Endocrinology · Tampa, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sainz De La Pena from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sainz De La Pena?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sainz De La Pena
Dr. Manuel Sainz De La Pena is an endocrinology specialist in Tampa, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sainz De La Pena performed 2,847 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sainz De La Pena received a total of $293,308 from 72 pharmaceutical and/or device companies across 1178 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sainz De La Pena is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 22% volume in FL
$293,308 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 55381 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗2,847
Medicare services
Top 22% in FL for endocrinology
Not available
Unique patients (not deduplicated)
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,620 | $18 | $47 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
569 | $90 | $273 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
194 | $62 | $186 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
104 | $134 | $366 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
88 | $26 | $91 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
77 | $101 | $350 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
71 | $117 | $415 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
36 | $83 | $417 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
27 | $52 | $195 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
25 | $10 | $27 |
| New patient office visit, complex (60-74 min) | 19 | $173 | $523 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
17 | $3 | $8 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$293,308
Total received (2018-2024)
Avg $41,901/year across 7 years
Top 4% in FL for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
1,178
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$13,174
2023
$43,773
2022
$61,178
2021
$20,330
2020
$16,118
2019
$47,579
2018
$91,156
Payments by company (2024)
Novo Nordisk Inc
$9,839
Amgen Inc.
$453
Boehringer Ingelheim Pharmaceuticals, Inc.
$283
SANOFI-AVENTIS U.S. LLC
$278
Bayer Healthcare Pharmaceuticals Inc.
$256
Lilly USA, LLC
$217
Abbott Laboratories
$197
Corcept Therapeutics
$196
Kyowa Kirin, Inc.
$164
Mannkind Corporation
$153
Esperion Therapeutics, Inc.
$140
CeQur Corporation
$122
Tandem Diabetes Care, Inc.
$105
RECORDATI_RARE_DISEASES_INC.
$99
Xeris Pharmaceuticals, Inc.
$96
Alexion Pharmaceuticals, Inc.
$88
Antares Pharma, Inc.
$69
Dexcom, Inc.
$68
Nevro Corp.
$65
Merck Sharp & Dohme LLC
$51
BETA BIONICS, INC.
$51
Insulet Corporation
$43
Avvisto Therapeutics, LLC
$34
Madrigal Pharmaceuticals
$23
Novartis Pharmaceuticals Corporation
$23
Renalytix AI, Inc.
$22
Amneal Pharmaceuticals LLC
$22
ABBVIE INC.
$16
Top 3 companies account for 80.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$229,801
Boehringer Ingelheim Pharmaceuticals, Inc.
$18,238
Bayer Healthcare Pharmaceuticals Inc.
$11,171
Bayer HealthCare Pharmaceuticals Inc.
$9,923
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$6,520
SANOFI-AVENTIS U.S. LLC
$4,107
Lilly USA, LLC
$1,763
Amgen Inc.
$953
Corcept Therapeutics
$952
Amarin Pharma Inc.
$766
Abbott Laboratories
$634
Senseonics, Incorporated
$632
AstraZeneca Pharmaceuticals LP
$626
Dexcom, Inc.
$511
Horizon Therapeutics plc
$429
RECORDATI_RARE_DISEASES_INC.
$398
Esperion Therapeutics, Inc.
$364
Tandem Diabetes Care, Inc.
$340
Xeris Pharmaceuticals, Inc.
$273
Mannkind Corporation
$269
Radius Health, Inc.
$253
Janssen Pharmaceuticals, Inc
$249
Insulet Corporation
$224
Amryt Pharma Holdings Ltd
$220
Nevro Corp.
$209
Shire North American Group Inc
$205
Amneal Pharmaceuticals LLC
$193
MannKind Corporation
$192
Kyowa Kirin, Inc.
$190
AbbVie Inc.
$181
AbbVie, Inc.
$181
IBSA Pharma Inc.
$170
DEXCOM, INC.
$133
Astellas Pharma US Inc
$126
CeQur Corporation
$122
Merck Sharp & Dohme Corporation
$119
Alexion Pharmaceuticals, Inc.
$119
ABBVIE INC.
$111
Companion Medical, Inc.
$100
United Therapeutics Corporation
$100
EUSA Pharma (US) LLC
$89
Valeritas, Inc.
$76
Medtronic, Inc.
$71
OPKO Pharmaceuticals, LLC
$70
Antares Pharma, Inc.
$69
Ascensia Diabetes Care Us Inc.
$68
PFIZER INC.
$66
Takeda Pharmaceuticals U.S.A., Inc.
$52
Merck Sharp & Dohme LLC
$51
Novartis Pharmaceuticals Corporation
$51
BETA BIONICS, INC.
$51
LifeScan, Inc.
$47
Zealand Pharma US, Inc.
$44
Kowa Pharmaceuticals America, Inc.
$35
Avvisto Therapeutics, LLC
$34
Medtronic MiniMed, Inc.
$33
Rhythm Pharmaceuticals, Inc.
$33
Acerus Pharmaceuticals Corporation
$32
LIFESCAN, INC.
$29
ARBOR PHARMACEUTICALS, INC.
$24
Madrigal Pharmaceuticals
$23
Ipsen Biopharmaceuticals, Inc
$23
Hikma Pharmaceuticals USA
$22
Renalytix AI, Inc.
$22
West-Ward Pharmaceuticals
$20
Ultragenyx Pharmaceutical Inc.
$19
Synergy Pharmaceuticals Inc
$19
GlaxoSmithKline, LLC.
$16
Teva Pharmaceuticals USA, Inc.
$14
VistaPharm, Inc.
$14
Medtronic USA, Inc.
$12
Orexigen Therapeutics, Inc.
$11
Top 3 companies account for 88.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AJOVY · Aimovig · Amitiza · BAQSIMI · BASAGLAR · BELSOMRA · CONTRAVE · CYCLOSET · CeQur Simplicity · Creon · Crysvita · DEXCOM CGM · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SMART TRANSMITTER KIT · Edarbi · Edarbyclor · Eversense · FARXIGA · FASENRA · FIASP · FREESTYLE LIBRE 2 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · INTELLIS · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · Korlym · LEQVIO · LICART · LYUMJEV · Livalo · MINIMED 780G · MOUNJARO · MULTAQ · MYCAPSSA · Minimed 670G System · Mitigare · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · Natesto · OT Verio Flex Starter Kit · Omnia · Omnipod · OneTouch · Otezla · Ozempic · PREVNAR - 13 · Prolia · RAYOS · RECORLEV · RESMETIROM · RYBELSUS · Rayaldee · Rayaldee (old) · Repatha · Rybelsus · SHINGRIX · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · SPIRIVA RESPIMAT · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Senza · Sylvant · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TYVASO · TZIELD · Thyquidity · Tirosint · Tresiba · Trintellix · Trulance · Tymlos · UBRELVY · UNITHROID · Uloric · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VESICARE · Vascepa · Victoza · WINREVAIR · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xultophy 100/3.6 · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
75
County median income
$75,011
Nearest hospital to ZIP centroid (approximate)
ST JOSEPHS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sainz De La Pena is a clinical cardiology specialist, with above-average Medicare volume (top 22% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sainz De La Pena experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Sainz De La Pena performed 1,620 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sainz De La Pena receive payments from pharmaceutical companies?
Yes. Dr. Sainz De La Pena received a total of $293,308 from 72 companies across 1,178 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sainz De La Pena's costs compare to other endocrinologists in Tampa?
Dr. Sainz De La Pena's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sainz De La Pena) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Tampa
Browse endocrinologists in Tampa ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in FL
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in FL
Which FL endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Bayer Healthcare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer Healthcare Pharmaceuticals Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology